Trial Profile
Safety and Effectiveness of Sofosbuvir in Combination with Simeprevir or Ribavirin for the Treatment of Hepatitis C Virus Recurrence after Liver Transplant
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Ribavirin (Primary) ; Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 07 Dec 2015 New trial record